Press Releases
Responsible Transparency Pharmaceutical companies will disclose transfers of value to healthcare professionals with the aim of increasing transparency
Pharmaceutical companies will disclose transfers of value to healthcare professionals, as part of a Europe-level initiative to apply a stricter self-regulatory framework in the sector and increase transparency. Details on the provisions of the revised “Code of Conduct...
Unacceptable to exclude medicines from the NHS.
KEFEA meeting with the Troika The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) greatly concerned over media reports which claim that only one medicine will be available for every disease following the implementation of the National...
Distorted picture on medicine prices. KEFEA is calling on the Auditor General to back up her claims of being threatened.
Constant references to “expensive” medicines and wrongful comparisons between the private sector prices in Cyprus and prices of other countries with comprehensive health systems, paint a distorted picture of medicine prices in Cyprus. The Cyprus Association of...
Meeting between KEFEA and the HIO Discussions focused on the GESY and patients’ access to innovative medicines.
The implementation of a modern and sustainable healthcare system, which will guarantee the provision of top-level health services and at the same time enable equitable access to innovative medicines for all patients, was the subject of discussion in a meeting between...
New Code of Practice by KEFEA Includes strict provisions on the promotion of prescription medicines to healthcare professionals.
Stricter provisions on the promotion of prescription medicines to healthcare professionals are among others points included in the revised Code of Practice by the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA). The new Code, which has...
Joanna Kozakou is the new president of KEFEA
Joanna Kozakou, Operations Manager of Sanofi, has assumed the position of President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), following the departure of Daan Gijbels from Cyprus who will undertake a new position as Area...
KEFEA welcomes the decision for the Medical School operation
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) welcomes the decision to operate the Medical School at the University of Cyprus come September and is pleased that the various obstacles have been overcome. KEFEA also congratulates...
KEFEA: We will not let patients go without medication
In response to reports claiming companies are not providing medication on credit as a result of the unfavourable for our country developments in the economy, the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) assures consumers that the...
Daan Gijbels is the new president of KEFEA
Mr Daan Gijbels, of Dutch descent and Area General Manager for GlaxoSmithKline (Cyprus), is the new president of the Cyprus Association of Research & Development Pharmaceutical Companies (KEFEA). He took over from Jacqueline Anastassiades, General Manager of Merck...
KEFEA met with Giorgos Lillikas
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), met with Presidential Candidate Giorgos Lillikas, within the framework of its meetings with the presidential candidates. "We had a very substantive dialogue with Mr. Lillikas and we...